Transcriptomic and Proteostasis Networks of CFTR and the Development of Small Molecule Modulators for the Treatment of Cystic Fibrosis Lung Disease
Cystic fibrosis (CF) is a lethal autosomal recessive disease caused by mutations in the CF transmembrane conductance regulator (<i>CFTR</i>) gene. The diversity of mutations and the multiple ways by which the protein is affected present challenges for therapeutic development. The observa...
Main Authors: | Matthew D. Strub, Paul B. McCray, Jr. |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/11/5/546 |
Similar Items
-
Adapting Proteostasis and Autophagy for Controlling the Pathogenesis of Cystic Fibrosis Lung Disease
by: Manish Bodas, et al.
Published: (2019-02-01) -
Targeting the intracellular environment in cystic fibrosis: restoring autophagy as a novel strategy to circumvent the CFTR defect
by: Valeria Rachela Villella, et al.
Published: (2013-01-01) -
Unravelling druggable signalling networks that control F508del-CFTR proteostasis
by: Ramanath Narayana Hegde, et al.
Published: (2015-12-01) -
Functional Consequences of CFTR Interactions in Cystic Fibrosis
by: Yashaswini Ramananda, et al.
Published: (2024-03-01) -
Cystic Fibrosis, CFTR, and Colorectal Cancer
by: Patricia Scott, et al.
Published: (2020-04-01)